Department of Biology, Neuroscience Program, Muskingum University, New Concord, OH 43762, USA.
Neuroscience. 2011 Oct 13;193:310-22. doi: 10.1016/j.neuroscience.2011.07.029. Epub 2011 Jul 20.
Whether dopamine (DA) release is compensated during the presymptomatic phase of Parkinson's disease (PD) is controversial. Here we use in vivo voltammetry in the parkinsonian rat and an electrical stimulation protocol established to fatigue nigrostriatal dopaminergic (DAergic) neurons to investigate the plasticity of DA-release mechanisms. Amplitudes of evoked voltammetric signals recorded in intact rat striata decreased with repetitive, high-frequency stimulation (60 Hz, every 5 min/60 min). Strikingly, DA levels were maintained during an identical "fatiguing" protocol in 6-hydroxydopamine-lesioned (<40% denervation) striata in the absence of enhanced DA synthesis. In contrast, more severely lesioned striata (>55% denervation) also appeared to sustain DA release, however, this was demonstrated in the presence of enhanced synthesis. Sustained release was replicated in intact animals after irreversible blockade of the dopamine transporter (DAT) via RTI-76, implicating neuronal uptake as a trigger. We further demonstrate through kinetic analysis that lesions and compromised uptake target a "long-term" (time constant of minutes) presynaptic depression, which underlies the maintenance of release. Taken together, our findings identify a denervation-induced maintenance of DA release that was independent of activated synthesis and driven by altered uptake. This novel neuroadaptation may contribute to early preclinical normalization of function and help resolve discrepant findings regarding compensatory changes in DA release during progression of the parkinsonian state.
在帕金森病(PD)的无症状前期,多巴胺(DA)释放是否得到代偿仍存在争议。在这里,我们使用帕金森大鼠的体内伏安法和建立的电刺激方案来疲劳黑质纹状体多巴胺能(DAergic)神经元,以研究 DA 释放机制的可塑性。在完整的大鼠纹状体中记录的诱发电化学信号的幅度随着重复的高频刺激(60 Hz,每 5 分钟/60 分钟)而降低。引人注目的是,在没有增强 DA 合成的情况下,在 6-羟多巴胺损伤(<40%去神经)纹状体中进行相同的“疲劳”方案时,DA 水平得以维持。相比之下,损伤更严重的纹状体(>55%去神经)似乎也能维持 DA 释放,但这是在增强合成的情况下证明的。不可逆地阻断多巴胺转运体(DAT)通过 RTI-76 后,在完整的动物中复制了持续释放,这表明神经元摄取是一个触发因素。我们通过动力学分析进一步证明,损伤和受损的摄取针对的是“长期”(分钟时间常数)的突触前抑制,这是维持释放的基础。综上所述,我们的研究结果表明,去神经诱导的 DA 释放的维持与激活的合成无关,而是由改变的摄取驱动的。这种新的神经适应可能有助于早期临床前功能的正常化,并有助于解决帕金森状态进展过程中 DA 释放代偿性变化的不一致发现。